Simone Kayser

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Vanya Icheva, Simone Kayser, Daniel Wolff et al. · Journal of Clinical Oncology · 2012 · 269 citations · Full text

Life Sciences, Hematology, Immunology +14

T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts

Judith Feucht, Simone Kayser, David Gorodezki et al. · Oncotarget · 2016 · 172 citations · Full text

Medicine, Hematology, Immunology +15

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Judith Feucht, Kathrin Opherk, Peter Lang et al. · Blood · 2015 · 145 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.

Christine Rentzsch, Simone Kayser, Susanne Stumm et al. · PubMed · 2003 · 56 citations

Life Sciences, Immunology, Oncology +17

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

Pauline Latzer, Henning Zelba, Florian Battke et al. · Nature Communications · 2024 · 54 citations · Full text

Medicine, Immunology, Oncology +17